Investigational Cancer Therapeutics Observer Program
Our faculty is dedicated to the mission of teaching evidence-based, patient-oriented care as it relates to clinical research. We strongly believe that teaching the “researchers of tomorrow” is a special calling which must be approached with care and dedication. As such, the Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program) Observer Program offers an outstanding educational experience for qualified applicants.
During a rotation, observers will have the opportunity to learn about new drug development and all aspects of clinical research, including, but not limited to, data management, budget issues, grants and contracts, protocol development and implementation, and patient care. The majority of our patient base consists of solid tumor patients.
The Department of Investigational Cancer Therapeutics offers one short-term observer position per month. Please note that we do not offer salary/benefits or sponsor visas. All travel arrangements and any costs incurred to participate in the observer program will be the sole responsibility of the observer.
Please note that this observer program is for our Phase I Clinical Trials Program. We do not coordinate observer programs for other departments. If you wish to pursue observer opportunities in other departments, please contact that department directly.
Terms of Appointment
Short-term observer appointments are limited to 30 days or less in a 12-month period
Observers may:
- Attend meetings, conferences, and lectures
- Observe clinics, the OR and rounds in accordance with appropriate medical staff policy
Observers may not:
- Perform a primary medical evaluation or a history and physical
- Obtain patient consent for any procedure (clinical or research)
- Participate in decisions concerning management of a patient
- Render treatment or other patient services
- Write in the medical record
- Order tests or services
- Wear a stethoscope when observing in clinic or on rounds, or in any other way give the impression that they are practicing physicians at MD Anderson Cancer Center
- Participate in research
- Provide service to The University of Texas MD Anderson Cancer Center
If you are interested in pursuing an observer opportunity, please forward an electronic copy of your current curriculum vitae and identify the length and dates you are requesting to observe.
We have currently filled all months through December 2013 and are not accepting applications until January 2014.
Contacts
Margaret Brown
Phone: 713-745-0147
mpbrown@mdanderson.org
Sarina Piha-Paul, MD, MS
Assistant Professor
Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program)
spihapau@mdanderson.org